Researchers at the European dermatology congress found 39% of users reported detached nails versus 9% of controls, plus more hair shedding. They urge awareness, not stopping treatment.
Recap by typeshit. Full story at New York Post.
One study cited by @fittrwithsquats put the risk of non-scarring hair loss about 40% higher with GLP-1 use, mostly telogen effluvium. Nail findings are less consistent.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Patients lost about 9% of body weight at 40 weeks in a 448 person trial, with fewer stomach side effects than Wegovy. Hanmi promises a lower price.
An eye doctor walks through the evidence on GLP-1 shots and vision, the rare warning signs to watch for and when to get urgent care.
Loading…